Results
21,570 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 14 | Mohan JitendraDirector, Chief Executive Officer |  ALABAstera Labs, Inc.Open-market sale · 10b5-1 plan | SELL | $644K 3,662 sh | Apr 21, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 14 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $644K 3,662 sh | Apr 21, 2026 |
| 14 | Pearson MarkDirector, President and CEO |  EQHEquitable Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $1.65M 39.7K sh | Apr 21, 2026 traded Apr 20, 2026 |
| 13 | Xu ZhenyuChief Scientific Officer |  SOPHSOPHiA GENETICS SAOpen-market sale · 10b5-1 plan | SELL | $3,165 608 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 13 | Camblong JurgiDirector, Chief Executive Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $23K 4,486 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 13 | Muken RossPresident | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $3,955 760 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 13 | Van Well DaanChief Legal Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $3,554 684 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 13 | Menu PhilippeChief Medical Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $3,162 608 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 12 | Bradbury Robyn LChief Financial Officer |  CNMCore & Main, Inc.Open-market sale · 10b5-1 plan | SELL | $86K 1,647 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 10 | Sevalia Piyush BSee Remarks |  SITMSITIME CorpOpen-market sale · 10b5-1 plan | SELL | $1.17M 2,419 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 8 | Edgemond JamesCFO AND TREASURER |  UTHRUNITED THERAPEUTICS CorpOpen-market sale · 10b5-1 plan | SELL | $885K 1,543 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $806K 1,398 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Ames Sophie CExec. Vice President & CHRO |  QBTSD-Wave Quantum Inc.Open-market sale · 10b5-1 plan | SELL | $66K 3,070 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Gibbons Mary LourdesSVP and Chief Legal Officer |  ESNTEssent Group Ltd.Open-market sale · 10b5-1 plan | SELL | $55K 872 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 8 | Garateix Ernie JDirector, Chief Executive Officer |  HRTGHeritage Insurance Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $221K 8,034 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Lewis BryanDirector, CEO/President |  IDNIntellicheck, Inc.Open-market sale · 10b5-1 plan | SELL | $85K 10.0K sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Collins Helen LouiseCHIEF MEDICAL OFFICER |  ELVNEnliven Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $115K 2,419 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 8 | Wasechek WayneEVP and CFO |  RYNRAYONIER INCOpen-market sale · 10b5-1 plan | SELL | $62K 2,920 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Collins Helen LouiseCHIEF MEDICAL OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $117K 2,441 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 7 | Llewellyn Lindsay CatherineSEE REMARKS |  LYFTLyft, Inc.Open-market sale · 10b5-1 plan | SELL | $355K 23.7K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 7 | Binder Kurtis JosephCHIEF FINANCIAL OFFICER |  ARLOArlo Technologies, Inc.Open-market sale · 10b5-1 plan | SELL | $380K 25.0K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 7 | Gibbons Mary LourdesSVP and Chief Legal Officer | ESNTEssent Group Ltd. Open-market sale · 10b5-1 plan | SELL | $481K 7,628 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 5 | Garateix Ernie JDirector, Chief Executive Officer | HRTGHeritage Insurance Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $8,521 300 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 5 | Kuhn Hallie E.EVP - Cap Market & Co-Lead -LS |  AREALEXANDRIA REAL ESTATE EQUITIES, INC.Open-market sale · 10b5-1 plan | SELL | $26K 536 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $254K 442 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $289K 500 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $581K 1,010 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $282K 482 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Hoffmann MartinCEO |  ONONOn Holding AGOpen-market sale · 10b5-1 plan | SELL | $152K 4,150 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $397K 687 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $284K 488 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $504K 880 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $573K 983 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $589K 1,009 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 3 | Rodman David MalcomChief Medical Officer |  MLYSMineralys Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $13K 416 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 1 | Collins Helen LouiseCHIEF MEDICAL OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $6,413 140 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 1 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $197K 340 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 1 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $139K 238 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 0 | Wren ChrisVP of Operations |  PLNHPlanet 13 Holdings Inc.Open-market sale · 10b5-1 plan | SELL | $4,521 30.0K sh | Apr 21, 2026 traded Apr 20, 2026 |
| 0 | Wren ChrisVP of Operations | PLNHPlanet 13 Holdings Inc. Open-market sale · 10b5-1 plan | SELL | $384 2,500 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 50 | Baugher Joshua ScottChief Financial Officer |  AGXARGAN INCOpen-market sale | SELL | $363K 600 sh | Apr 20, 2026 traded Apr 16, 2026 |